Andre Goy, MD | Authors


Venetoclax Plus Ibrutinib Combo Shows Potential in Relapsed/Refractory MCL

December 17, 2019

Andre Goy, MD, discusses the results from a small clinical trial, which was presented at the 2019 American Society of Hematology Annual Meeting that he found particularly significant for the treatment of patients with relapsed/refractory mantle cell lymphoma.